Robert James Finlayson
ORCID：0000-0002-9981-632X
发表论文 85 篇 · 总被引 4210 次 · h-index 31
代表论文
- Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials (2018 · The Lancet · 被引 391)
- Population-level effectiveness of rapid, targeted, high-coverage roll-out of HIV pre-exposure prophylaxis in men who have sex with men: the EPIC-NSW prospective cohort study (2018 · The Lancet HIV · 被引 375)
- Phase 2 gene therapy trial of an anti-HIV ribozyme in autologous CD34+ cells (2009 · Nature Medicine · 被引 263)
- Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 48-week results of a randomised, double-blind, phase 3, non-inferiority trial (2018 · The Lancet HIV · 被引 150)
- Long-term protection from HIV infection with oral HIV pre-exposure prophylaxis in gay and bisexual men: findings from the expanded and extended EPIC-NSW prospective implementation study (2021 · The Lancet HIV · 被引 104)
- Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 96-week results of a randomised, double-blind, non-inferiority, phase 3 trial (2019 · The Lancet HIV · 被引 101)